Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

230 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans.
Tsiantoulas D, Eslami M, Obermayer G, Clement M, Smeets D, Mayer FJ, Kiss MG, Enders L, Weißer J, Göderle L, Lambert J, Frommlet F, Mueller A, Hendrikx T, Ozsvar-Kozma M, Porsch F, Willen L, Afonyushkin T, Murphy JE, Fogelstrand P, Donzé O, Pasterkamp G, Hoke M, Kubicek S, Jørgensen HF, Danchin N, Simon T, Scharnagl H, März W, Borén J, Hess H, Mallat Z, Schneider P, Binder CJ. Tsiantoulas D, et al. Among authors: binder cj. Nature. 2021 Sep;597(7874):92-96. doi: 10.1038/s41586-021-03818-3. Epub 2021 Aug 25. Nature. 2021. PMID: 34433968
B cell depletion reduces the development of atherosclerosis in mice.
Ait-Oufella H, Herbin O, Bouaziz JD, Binder CJ, Uyttenhove C, Laurans L, Taleb S, Van Vré E, Esposito B, Vilar J, Sirvent J, Van Snick J, Tedgui A, Tedder TF, Mallat Z. Ait-Oufella H, et al. Among authors: binder cj. J Exp Med. 2010 Aug 2;207(8):1579-87. doi: 10.1084/jem.20100155. Epub 2010 Jul 5. J Exp Med. 2010. PMID: 20603314 Free PMC article.
Complement factor H binds malondialdehyde epitopes and protects from oxidative stress.
Weismann D, Hartvigsen K, Lauer N, Bennett KL, Scholl HP, Charbel Issa P, Cano M, Brandstätter H, Tsimikas S, Skerka C, Superti-Furga G, Handa JT, Zipfel PF, Witztum JL, Binder CJ. Weismann D, et al. Among authors: binder cj. Nature. 2011 Oct 5;478(7367):76-81. doi: 10.1038/nature10449. Nature. 2011. PMID: 21979047 Free PMC article.
Group X secreted phospholipase A2 limits the development of atherosclerosis in LDL receptor-null mice.
Ait-Oufella H, Herbin O, Lahoute C, Coatrieux C, Loyer X, Joffre J, Laurans L, Ramkhelawon B, Blanc-Brude O, Karabina S, Girard CA, Payré C, Yamamoto K, Binder CJ, Murakami M, Tedgui A, Lambeau G, Mallat Z. Ait-Oufella H, et al. Among authors: binder cj. Arterioscler Thromb Vasc Biol. 2013 Mar;33(3):466-73. doi: 10.1161/ATVBAHA.112.300309. Epub 2013 Jan 24. Arterioscler Thromb Vasc Biol. 2013. PMID: 23349189
B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction.
Zouggari Y, Ait-Oufella H, Bonnin P, Simon T, Sage AP, Guérin C, Vilar J, Caligiuri G, Tsiantoulas D, Laurans L, Dumeau E, Kotti S, Bruneval P, Charo IF, Binder CJ, Danchin N, Tedgui A, Tedder TF, Silvestre JS, Mallat Z. Zouggari Y, et al. Among authors: binder cj. Nat Med. 2013 Oct;19(10):1273-80. doi: 10.1038/nm.3284. Epub 2013 Sep 15. Nat Med. 2013. PMID: 24037091 Free PMC article.
An unexpected intriguing effect of Toll-like receptor regulator RP105 (CD180) on atherosclerosis formation with alterations on B-cell activation.
Karper JC, de Jager SC, Ewing MM, de Vries MR, Bot I, van Santbrink PJ, Redeker A, Mallat Z, Binder CJ, Arens R, Jukema JW, Kuiper J, Quax PH. Karper JC, et al. Among authors: binder cj. Arterioscler Thromb Vasc Biol. 2013 Dec;33(12):2810-7. doi: 10.1161/ATVBAHA.113.301882. Epub 2013 Oct 10. Arterioscler Thromb Vasc Biol. 2013. PMID: 24115036
B cells and humoral immunity in atherosclerosis.
Tsiantoulas D, Diehl CJ, Witztum JL, Binder CJ. Tsiantoulas D, et al. Among authors: binder cj. Circ Res. 2014 May 23;114(11):1743-56. doi: 10.1161/CIRCRESAHA.113.301145. Circ Res. 2014. PMID: 24855199 Free PMC article. Review.
Atheroprotective immunization with malondialdehyde-modified LDL is hapten specific and dependent on advanced MDA adducts: implications for development of an atheroprotective vaccine.
Gonen A, Hansen LF, Turner WW, Montano EN, Que X, Rafia A, Chou MY, Wiesner P, Tsiantoulas D, Corr M, VanNieuwenhze MS, Tsimikas S, Binder CJ, Witztum JL, Hartvigsen K. Gonen A, et al. Among authors: binder cj. J Lipid Res. 2014 Oct;55(10):2137-55. doi: 10.1194/jlr.M053256. Epub 2014 Aug 20. J Lipid Res. 2014. PMID: 25143462 Free PMC article.
230 results